List of Bolder Biotechnology patents

Patents where

Current Assignee

Name

‌

Bolder Biotechnology

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7153943 Derivatives of growth hormone and related proteins, and methods of use thereof	Patent 7153943 was granted and assigned to Bolder Biotechnology on December, 2006 by the United States Patent and Trademark Office.		‌ Bolder Biotechnology	United States Patent and Trademark Office	7153943	December 26, 2006
‌ US Patent 7148333 Cysteine variants of granulocyte-macrophage colony-stimulating factor	Patent 7148333 was granted and assigned to Bolder Biotechnology on December, 2006 by the United States Patent and Trademark Office.		‌ Bolder Biotechnology	United States Patent and Trademark Office	7148333	December 12, 2006
‌ US Patent 7309781 Cysteine variants of granulocyte colony-stimulating factor	Patent 7309781 was granted and assigned to Bolder Biotechnology on December, 2007 by the United States Patent and Trademark Office.		‌ Bolder Biotechnology	United States Patent and Trademark Office	7309781	December 18, 2007
‌ US Patent 7345149 Cysteine substitution variants of beta interferon	Patent 7345149 was granted and assigned to Bolder Biotechnology on March, 2008 by the United States Patent and Trademark Office.		‌ Bolder Biotechnology	United States Patent and Trademark Office	7345149	March 18, 2008
‌ US Patent 7214779 Termini cysteine-added variants of granulocyte-macrophage colony stimulating factor	Patent 7214779 was granted and assigned to Bolder Biotechnology on May, 2007 by the United States Patent and Trademark Office.		‌ Bolder Biotechnology	United States Patent and Trademark Office	7214779	May 8, 2007
‌ US Patent 7754855 Immunoglobulin fusion proteins	Patent 7754855 was granted and assigned to Bolder Biotechnology on July, 2010 by the United States Patent and Trademark Office.		‌ Bolder Biotechnology	United States Patent and Trademark Office	7754855	July 13, 2010
‌ US Patent 7306931 Method for refolding proteins containing free cysteine residues	Patent 7306931 was granted and assigned to Bolder Biotechnology on December, 2007 by the United States Patent and Trademark Office.		‌ Bolder Biotechnology	United States Patent and Trademark Office	7306931	December 11, 2007
‌ US Patent 7399839 Monopegylated growth hormone proteins	Patent 7399839 was granted and assigned to Bolder Biotechnology on July, 2008 by the United States Patent and Trademark Office.		‌ Bolder Biotechnology	United States Patent and Trademark Office	7399839	July 15, 2008
‌ US Patent 7629314 Methods for making proteins containing free cysteine residues	Patent 7629314 was granted and assigned to Bolder Biotechnology on December, 2009 by the United States Patent and Trademark Office.		‌ Bolder Biotechnology	United States Patent and Trademark Office	7629314	December 8, 2009
‌ US Patent 7495087 Cysteine muteins in the C-D loop of human interleukin-11	Patent 7495087 was granted and assigned to Bolder Biotechnology on February, 2009 by the United States Patent and Trademark Office.		‌ Bolder Biotechnology	United States Patent and Trademark Office	7495087	February 24, 2009
‌ US Patent 8133480 Cysteine variants of interleukin-11	Patent 8133480 was granted and assigned to Bolder Biotechnology on March, 2012 by the United States Patent and Trademark Office.		‌ Bolder Biotechnology	United States Patent and Trademark Office	8133480	March 13, 2012
‌ US Patent 9296804 NH2-terminal glutamine modified cysteine variants of interferon gamma	Patent 9296804 was granted and assigned to Bolder Biotechnology on March, 2016 by the United States Patent and Trademark Office.	‌ Bolder Biotechnology	‌ Bolder Biotechnology	United States Patent and Trademark Office	9296804	March 29, 2016
‌ US Patent 8932828 Method for preparing recombinant granulocyte colony stimulating factor cysteine muteins	Patent 8932828 was granted and assigned to Bolder Biotechnology on January, 2015 by the United States Patent and Trademark Office.		‌ Bolder Biotechnology	United States Patent and Trademark Office	8932828	January 13, 2015
‌ US Patent 7824669 In vivo stimulation of peripheral blood progenitor cells by granulocyte-macrophage colony stimulating factor (GM-CSF) cysteine muteins and their PEGylated variants	Patent 7824669 was granted and assigned to Bolder Biotechnology on November, 2010 by the United States Patent and Trademark Office.		‌ Bolder Biotechnology	United States Patent and Trademark Office	7824669	November 2, 2010
‌ US Patent 8329866 Long acting VEGF inhibitors and methods of use	Patent 8329866 was granted and assigned to Bolder Biotechnology on December, 2012 by the United States Patent and Trademark Office.		‌ Bolder Biotechnology	United States Patent and Trademark Office	8329866	December 11, 2012
‌ US Patent 9320777 Methods and use of growth hormone supergene family protein analogs for treatment of radiation exposure	Patent 9320777 was granted and assigned to Bolder Biotechnology on April, 2016 by the United States Patent and Trademark Office.		‌ Bolder Biotechnology	United States Patent and Trademark Office	9320777	April 26, 2016
‌ US Patent 9637530 Methods of preparing cysteine variants of human recombinant IL-11	Patent 9637530 was granted and assigned to Bolder Biotechnology on May, 2017 by the United States Patent and Trademark Office.	‌ Bolder Biotechnology	‌ Bolder Biotechnology	United States Patent and Trademark Office	9637530	May 2, 2017
‌ US Patent 7947655 Methods for making proteins containing free cysteine residues	Patent 7947655 was granted and assigned to Bolder Biotechnology on May, 2011 by the United States Patent and Trademark Office.		‌ Bolder Biotechnology	United States Patent and Trademark Office	7947655	May 24, 2011
‌ US Patent 10329337 Method to increase the number of circulating platelets by administering PEGylated cysteine variants of IL-11	Patent 10329337 was granted and assigned to Bolder Biotechnology on June, 2019 by the United States Patent and Trademark Office.	‌ Bolder Biotechnology	‌ Bolder Biotechnology	United States Patent and Trademark Office	10329337	June 25, 2019
‌ US Patent 8859497 Method of treatment using cysteine mutants of beta interferon	Patent 8859497 was granted and assigned to Bolder Biotechnology on October, 2014 by the United States Patent and Trademark Office.	‌ Bolder Biotechnology	‌ Bolder Biotechnology	United States Patent and Trademark Office	8859497	October 14, 2014
‌ US Patent 7732572 Cysteine variants of alpha interferon-2	Patent 7732572 was granted and assigned to Bolder Biotechnology on June, 2010 by the United States Patent and Trademark Office.		‌ Bolder Biotechnology	United States Patent and Trademark Office	7732572	June 8, 2010
‌ US Patent 7795396 COOH-terminally added cysteine variant of the beta interferon	Patent 7795396 was granted and assigned to Bolder Biotechnology on September, 2010 by the United States Patent and Trademark Office.		‌ Bolder Biotechnology	United States Patent and Trademark Office	7795396	September 14, 2010
‌ US Patent 7345154 Cysteine variants of erythropoietin	Patent 7345154 was granted and assigned to Bolder Biotechnology on March, 2008 by the United States Patent and Trademark Office.		‌ Bolder Biotechnology	United States Patent and Trademark Office	7345154	March 18, 2008
‌ US Patent 8748392 Methods of treatment using cysteine variants of interleukin-11	Patent 8748392 was granted and assigned to Bolder Biotechnology on June, 2014 by the United States Patent and Trademark Office.		‌ Bolder Biotechnology	United States Patent and Trademark Office	8748392	June 10, 2014
‌ US Patent 7270809 Cysteine variants of alpha interferon-2	Patent 7270809 was granted and assigned to Bolder Biotechnology on September, 2007 by the United States Patent and Trademark Office.		‌ Bolder Biotechnology	United States Patent and Trademark Office	7270809	September 18, 2007

Results per page:

34 results

0 selected

34 results

0 selected